Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Deutsche Boerse AG  >  Epigenomics AG    ECX   DE000A11QW50

EPIGENOMICS AG (ECX)
Mes dernières consult.
Most popular
  Report  
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsofficial PublicationsSector newsTweets
The feature you requested does not exist. However, we suggest the following feature:

Epigenomics AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

share with twitter share with LinkedIn share with facebook
share via e-mail
0
05/22/2018 | 05:25pm CEST

DGAP Voting Rights Announcement: Epigenomics AG
Epigenomics AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

22.05.2018 / 17:13
Dissemination of a Voting Rights Announcement transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


Notification of Major Holdings

1. Details of issuer
Epigenomics AG
Geneststraße 5
10829 Berlin
Germany

2. Reason for notification
  Acquisition/disposal of shares with voting rights
  Acquisition/disposal of instruments
  Change of breakdown of voting rights
X Other reason:
Exercise of instrument (Obligation to rescind Rollover)

3. Details of person subject to the notification obligation
Name: City and country of registered office:
Mr Yong Yu,
Date of birth: 27 Feb 1961

4. Names of shareholder(s)
holding directly 3% or more voting rights, if different from 3.
Cathay Fortune International Company Limited

5. Date on which threshold was crossed or reached:
18 May 2018

6. Total positions
  % of voting rights attached to shares
(total of 7.a.)
% of voting rights through instruments
(total of 7.b.1 + 7.b.2)
total of both in %
(7.a. + 7.b.)
total number of voting rights of issuer
Resulting situation 4.84 % 4.14 % 8.98 % 24014360
Previous notification 4.84 % 8.98 % 8.98 % /

7. Notified details of the resulting situation
a. Voting rights attached to shares (Sec.s 33, 34 WpHG)
ISIN absolute in %
  direct
(Sec. 33 WpHG)
indirect
(Sec. 34 WpHG)
direct
(Sec. 33 WpHG)
indirect
(Sec. 34 WpHG)
DE000A11QW50 0 1161139 0 % 4.84 %
Total 1161139 4.84 %

b.1. Instruments according to Sec. 38 para. 1 No. 1 WpHG
Type of instrument Expiration or maturity date Exercise or conversion period Voting rights absolute Voting rights in %
%
    Total %

b.2. Instruments according to Sec. 38 para. 1 No. 2 WpHG
Type of instrument Expiration or maturity date Exercise or conversion period Cash or physical settlement Voting rights absolute Voting rights in %
Convertible bond 31.12.2018 07.09.2017 until 31.12.2018 Physical 994397 4.14 %
      Total 994397 4.14 %

8. Information in relation to the person subject to the notification obligation
  Person subject to the notification obligation is not controlled and does itself not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer (1.).
X Full chain of controlled undertakings starting with the ultimate controlling natural person or legal entity:

Name % of voting rights (if at least held 3% or more) % of voting rights through instruments (if at least held 5% or more) Total of both (if at least held 5% or more)
Yong Yu % % %
Cathay Fortune Corp. % % %
Cathay Fortune International Company Limited 4.84 % % 8.98 %

9. In case of proxy voting according to Sec. 34 para. 3 WpHG

Date of general meeting:
Holding position after general meeting: % (equals voting rights)

10. Other explanatory remarks:
 



22.05.2018 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de


Language: English
Company: Epigenomics AG
Geneststraße 5
10829 Berlin
Germany
Internet: www.epigenomics.com

 
End of News DGAP News Service

688441  22.05.2018 

fncls.ssp?fn=show_t_gif&application_id=688441&application_name=news&site_id=zonebourse

© EQS 2018
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on EPIGENOMICS AG
05/22EPIGENOMICS AG : Release according to Article 40, Section 1 of the WpHG [the Ger..
EQ
05/09EPIGENOMICS : announces 2018 First Quarter Financial Results
PU
05/09EPIGENOMICS : announces 2018 First Quarter Financial Results
EQ
05/07EPIGENOMICS AG : Preliminary announcement of the publication of quarterly report..
EQ
04/20EPIGENOMICS AG : Announcement of the Convening of the General Meeting in Berlin..
EQ
04/19EPIGENOMICS AG : Blood test shows promise in the detection of liver cancer
EQ
04/17EPIGENOMICS AG : Notice of Loss pursuant to § 92 par. 1 AktG
PU
04/17EPIGENOMICS AG : Notice of Loss pursuant to § 92 par. 1 AktG
EQ
03/23EPIGENOMICS : Reports Results for Financial Year 2017
EQ
03/20EPIGENOMICS AG : Preliminary announcement of the publication of financial report..
EQ
More news
News from SeekingAlpha
03/27Epigenomics AG 2017 Q4 - Results - Earnings Call Slides 
03/23Epigenomics' (EPGNF) CEO Gregory Hamilton on Q4 2017 Results - Earnings Call .. 
03/23Epigenomics reports FY results 
2017Epigenomics AG 2017 Q3 - Results - Earnings Call Slides 
2017Epigenomics' (EPGNF) CEO Gregory Hamilton on Q3 2017 Results - Earnings Call .. 
Financials (€)
Sales 2018 3,37 M
EBIT 2018 -12,7 M
Net income 2018 -11,7 M
Finance 2018 54,8 M
Yield 2018 -
P/E ratio 2018 -
P/E ratio 2019
EV / Sales 2018 11,4x
EV / Sales 2019 1,65x
Capitalization 93,2 M
Chart EPIGENOMICS AG
Duration : Period :
Epigenomics AG Technical Analysis Chart | ECX | DE000A11QW50 | 4-Traders
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 2
Average target price 5,91 €
Spread / Average Target 51%
EPS Revisions
Managers
NameTitle
Gregory K. Hamilton Chief Executive Officer
Jorge A. Garces President & Chief Scientific Officer
Heino von Prondzynski Chairman-Supervisory Board
Günther Reiter Vice Chairman-Supervisory Board
Ann Clare Kessler Member-Supervisory Board
Sector and Competitors
1st jan.Capitalization (M$)
EPIGENOMICS AG-7.45%109
GENSCRIPT BIOTECH CORP45.48%6 216
MIRACA HOLDINGS INC.-27.27%1 865
IOVANCE BIOTHERAPEUTICS INC99.38%1 429
BEIJING STRONG BIOTECHNOLOGIES INC--.--%1 328
SEEGENE INC--.--%769